Impact of Epicardial Anterior Fat Pad Retention on Postcardiothoracic Surgery Atrial Fibrillation Incidence The AFIST-III Study by White, C. Michael et al.
T
p
(
t
I
p
c
l
i
t
r
F
H
S
F
W
s
t
a
Journal of the American College of Cardiology Vol. 49, No. 3, 2007
© 2007 by the American College of Cardiology Foundation ISSN 0735-1097/07/$32.00
PImpact of Epicardial Anterior Fat Pad Retention on
Postcardiothoracic Surgery Atrial Fibrillation Incidence
The AFIST-III Study
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Robert Gallagher, MD,† Hiroyoshi Takata, MD,† Chester Humphrey, MD,†
Nickole Henyan, PHARMD,‡§ Effie L. Gillespie, PHARMD,‡§ Jeffrey Kluger, MD*
Hartford, Storrs, and Farmington, Connecticut
Objectives We conducted a randomized, blinded, controlled study evaluating the impact of anterior fat pad (AFP) mainte-
nance on postoperative atrial fibrillation (POAF) incidence.
Background Drugs with antiadrenergic effects reduce POAF. Because the epicardial AFP is parasympathetically innervated,
its routine excision during coronary artery bypass grafting (CABG) might precipitate autonomic imbalance and
induce POAF.
Methods Patients (n  180, mean age  66  10 years, 80% men, 5% with previous atrial fibrillation) undergoing CABG
surgery were randomized to either AFP maintenance or AFP removal. Routine prophylaxis against POAF with
beta-blockers (85%) and amiodarone (28%) was allowed on the basis of caregivers’ discretion. The development
of POAF, total hospital costs, and heart rate variability was compared between groups.
Results Anterior fat pad maintenance did not reduce POAF incidence (34.8% vs. 35.2%, p  0.950) or total hospital
costs (data as medians with 25%, 75% percentiles: $22,940 [$17,629, $29,274] vs. $23,866 [$18,602,
$30,370], p  0.647) but was associated with higher heart rate variability (SD of normal-to-normal RR intervals
[SDNN]: 31.7  24.6 vs. 22.7  8.3, p  0.05 and SD of all 5-min mean RR intervals [SDANN 5]: 17.1  11.9
vs. 10.1  5.5, p  0.003) than AFP removal.
Conclusions Maintaining the AFP prevents attenuation of parasympathetic tone after CABG but does not reduce POAF
or total hospital costs in any appreciable way. (J Am Coll Cardiol 2007;49:298–303) © 2007 by the
American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.10.033c
i
e
t
u
s
p
a
s
p
o
t
o
t
t
w
the heart has 3 epicardial fat pads (FPs) containing
arasympathetic ganglia (1–4). In 1997, an anterior fat pad
AFP) was discovered and located on the anterior surface of
he atria between the aorta and right pulmonary artery (1).
n canines, the AFP is the conduit of most efferent
arasympathetic nerve fibers en-route to the “superior vena
aval-right atrial (SVC-RA) FP” and “inferior vena caval-
eft atrial (IVC-LA) FP” (1). Nerve stimulation of the AFP
n canines increases atrial cycle length, slows the atrioven-
ricular conduction time, and shortens the atrial effective
efractory period (AERP) (1,2). Shortening AERP de-
rom the Divisions of *Cardiology, †Surgery, and ‡Drug Information, Hartford
ospital, Hartford, Connecticut; §University of Connecticut School of Pharmacy,
torrs, Connecticut; and the University of Connecticut School of Medicine,
armington, Connecticut. This study was supported by the Patrick and Catherine
eldon Donaghue Medical Research Foundation, West Hartford, Connecticut. This
tudy was not registered before initiation. Enrollment began in August of 2004, before
he requirement was made.o
Manuscript received July 24, 2006; revised manuscript received August 29, 2006,
ccepted September 11, 2006.reases the wavelength of atrial excitation wave fronts and
ncreases the chances of developing atrial fibrillation. Cath-
ter ablation of the AFP in 2 canine studies has been shown
o prevent or attenuate AERP shortening with nerve stim-
lation (1,2). In these studies, ablation of the AFP was also
hown to prevent inducibility for atrial fibrillation. In
atients, nerve stimulation of the SVC-RA FP increases the
trial cycle length, whereas stimulation of the IVC-LA FP
lows atrioventricular conduction times (3,4).
The AFP is frequently removed in cardiothoracic surgery
atients to fully expose the aortic root (5–7). Extrapolation
f canine data suggests that AFP excision during cardio-
horacic surgery would reduce the risk of developing post-
perative atrial fibrillation (POAF) (3,4). In 1 small cardio-
horacic surgery patient study (n 55), nerve stimulation of
he AFP reduced the heart rate, whereas no change occurred
ith repeat nerve stimulation to the area of the removed
issue (5). Paradoxically, as a secondary end point, the rate
f POAF with AFP removal was 37% as compared with 7%
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January 23, 2007:298–303 Anterior Fat Pad and AFn patients whose tissue was left intact (p  0.01) (5). In a
andomized pilot study (n  131), the incidence of POAF
n patients who had the AFP removed was 21% versus 7%
f patients with AFP retention (p  0.051) (6,7). In a
onrandomized (i.e., convenience sample on the basis of
linical judgment at surgery) extension of this study, 189
ore patients were included (n  320 total) (7). With
ogistic regression analysis, there was no benefit associated
ith AFP retention versus removal (odds ratio [OR] 1.0,
5% confidence interval [CI] 0.4 to 2.4).
Given conflicting preliminary data (1,2,5–7), we con-
ucted the AFIST-III (Atrial Fibrillation Suppression
rial-III), a randomized, blinded, and controlled trial de-
igned to evaluate the impact of maintaining the AFP on
OAF. In addition, we evaluated the impact of AFP
aintenance on heart rate variability, an established marker
f parasympathetic tone, in order to explore the underlying
echanism (8,9).
ethods
tudy design. Patients (n  180) undergoing coronary
rtery bypass graft surgery (CABG) were randomized to
ither removal or maintenance of the AFP and were
ollowed for 30 days after their surgery. Although the
ardiothoracic surgeons were not blinded, study subjects and
ata collectors did not know treatment group allocation.
The primary aims were to determine the impact of AFP
aintenance on the incidence of POAF and the cost of
ABG surgery. Secondary aims of this study were to
valuate hospital length of stay, determine the impact of
FP removal on parasympathetic activity via heart rate
ariability (HRV) measurement, and determine the impact
f AFP retention on several safety parameters (another
rrhythmia, myocardial infarction, hypotension, bradycar-
ia, mortality, and stroke). Current standard of care mea-
ures, including surgical techniques (on- vs. off-pump sur-
ery) and medications (prophylactic beta-blockers and
miodarone), were completely under the discretion of the
atients’ caregivers. The Institutional Review Board at
artford Hospital approved the study with written in-
ormed consent obtained before surgery.
tudy subjects. From August 2004 through October 2005,
atients over 50 years of age scheduled to undergo their first
ABG surgery (the AFP would already be removed for
e-do CABG and would be a confounder) at Hartford
ospital, a 600-bed teaching hospital, were screened. Pa-
ients were excluded if: 1) they were experiencing an atrial
rrhythmia (atrial fibrillation or flutter) at the time of
nrollment, 2) they were scheduled to undergo concomitant
rocedures along with their CABG surgery such as valve
eplacement, or 3) they were enrolled in any other clinical
rial.
Overall, 356 of 536 patients screened were excluded from
articipating for the following reasons: age 50 (n  19),
trial arrhythmia at the time of enrollment (n 15), alreadynrolled in a competing study (n
1), concomitant valve replace-
ent or MAZE procedure (n 
93), physician refusal (n  1), or
efusal to participate (n  108)
Fig. 1).
urgicalmethodology. Sternot-
my and endoscopic vein har-
esting along with standard sur-
ical techniques, including both
n- and off-cardiopulmonary by-
ass (CPB) surgeries, were con-
ucted by 1 of 3 surgeons. For removal of the AFP, excision
as made with cautery and scissors, and the epicardial
dipose tissue located between the aorta and the pulmonary
rtery often extending onto much of the anterior surface was
issected. The AFP excision was made for the purpose of
xposing the aorta but was not necessary to conduct the
peration. In patients randomized to AFP maintenance, the
urgeon would avoid excision into the area of the AFP,
hereby preserving the nerve fibers if possible.
atient management. As part of the institution’s cardio-
horacic surgery critical pathway, the preprinted admission
rder sheet includes beta-blockers. After direct transfer
rom the operating room, patients were initially cared for
ithin the surgical intensive care unit before being trans-
erred to a monitored bed. The hospital telemetry instru-
ents (Marquette, Milwaukee, Wisconsin) save all rhythms
or 24 h and all abnormal rhythms until disconnected. A
linded certified technician continuously monitors and
rints alarm-triggered abnormal strips. Blinded hospital
Abbreviations
and Acronyms
AFP  anterior fat pad
CABG  coronary artery
bypass graft (surgery)
CI  confidence interval
HRV  heart rate variability
OR  odds ratio
POAF  postoperative
atrial fibrillationFigure 1 Schematic Diagram of Study
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Anterior Fat Pad and AF January 23, 2007:298–303linicians provided patient care of all arrhythmias, including
he prophylaxis and treatment of POAF. A blinded study
nvestigator monitored the time of occurrence, duration,
nd treatment of all arrhythmias and collected study data.
atients were followed daily until hospital discharge and
hen followed up periodically for 30 days after surgery.
efinitions. The following definitions were used:
POAF”: POAF of more than 5 min in duration; “symp-
omatic POAF”: POAF associated with hemodynamic
ompromise (hypotension, heart failure), requiring treat-
ent (intravenous administration of an intravenous rate-
ontrolling or antiarrhythmic agent), or feelings of subjec-
ive discomfort (palpitations, chest pain, shortness of breath,
yncope); “recurrent POAF”: POAF after being in sinus
hythm for more than 24 h after the initial episode;
cerebrovascular accident”: development of a stroke (docu-
entation by an attending neurologist of a focal deficit
asting more than 24 h, with confirmation or cerebral
nfarction by brain computed tomography or magnetic
esonance imaging) or transient ischemic attack (documen-
ation of a focal neurological deficit lasting for 24 h); and
ventricular tachycardia”: ventricular tachycardia lasting at
east 30 s or requiring treatment for termination.
otal hospital costs. Our cost analysis was conducted
rom a hospital perspective. Total hospital costs for each
atient enrolled in the trial was determined, including all
osts accrued starting from the day of admission for surgery
hrough hospital discharge. Hospital charges as well as a
reakdown of charges/cost center were obtained from our
nstitution’s medical claims database. Hospital-derived, de-
artmental cost/charge ratios were used to convert hospital
harges to hospital costs. Owing to the short-term nature of
he study, discounting was not performed. All costs were
djusted to and reported in 2005 U.S. dollars (as median
ith 25% and 75% ranges) with the Consumer Price Index
or Medical Care.
RV. Holter monitors were placed on patients for at least
0 min on postoperative day 2. Holter monitors were
ttached by a trained study investigator or certified techni-
ian to patients in a supine position at a similar time each
ay, at least 1 h after the afternoon meal. The HRV was not
etermined in subjects experiencing POAF at the scheduled
olter monitoring time.
Digital Holter images were scanned and analyzed with
hilips Zymed Holter 2120 Plus (Philips Medical Systems
ndover, Massachusetts) by a certified technician. Analysis
f HRV included measurement of the SD of normal-to-
ormal time duration between 2 consecutive R waves (RR
ntervals) (SDNN) and the SD of all 5-min mean RR
ntervals (SDANN 5). Patients having any atrial fibrillation
r 5 or more supraventricular beats within the analysis
eriod were excluded before between-group statistical com-
arison in order to reduce the influence of sinus alternans on
ur results. Average heart rates from Holter data were also
etermined and analyzed. ftatistical analysis. All demographic, clinical, safety, and
ength of stay data are presented as means  SD. Cost data
s expressed as medians with 25% and 75% percentiles.
alues of p  0.05 are considered statistically significant.
ichotomous variables were compared with chi-square
nalysis, whereas continuous variables were compared with
npaired t tests. All statistical tests were run with SPSS
ersion 11.0 (SPSS Inc., Chicago, Illinois).
ogistic regression. Univariate analysis was conducted to
xamine the association between the occurrence of POAF
dependant variable) and preoperative, intraoperative, and
ostoperative variables (independent variables). All variables
ith a p value of 0.2 in the univariate analysis were
ntered into a multivariate logistic regression model. In
ddition, variables that were not identified as univariate
redictors of POAF but that have been previously identified
s predictors were also included into the multivariate model.
n the multivariate model, variables were selected by step-
ise, backward elimination, and a p value  0.05 was
onsidered significant. Odds ratios and 95% CIs were
alculated for all independent predictors of POAF. Sta-
istical analysis was conducted with SPSS version 11.0
SPSS Inc.).
The authors had full access to the data and take respon-
ibility for its integrity. All authors have read and agree to
he report as written.
esults
atients were well matched at baseline except that patients
n the AFP removed group had a lower incidence of
moking than those receiving AFP maintenance (60.2% vs.
2.8%, p  0.043) and showed a trend toward fewer vein
rafts (2.0  1.3 vs. 2.4  1.3, p  0.059) (Table 1).
rophylactic beta-blockers and amiodarone were used in
pproximately 85% and 28% of subjects, respectively.
No difference in the incidence of POAF (OR 0.981;
5% CI 0.531 to 1.810), symptomatic POAF, or recur-
ent POAF occurred between groups (Table 2). Simi-
arly, no difference in any safety or length-of-hospital-
tay parameter or total hospital costs occurred between
roups (Table 2).
Subjects with AFP removal had lower HRV than those with
FP maintenance as determined by the SDNN (22.7 8.3 vs.
1.7  24.6, p  0.05) and SDANN 5 (10.1  5.5 vs.
7.1  11.9, p  0.003). The average heart rate during
olter monitoring was similar between the AFP removed
nd maintained groups (84.7  12.4 vs. 84.9  10.5, p 
.924). Subjects who subsequently developed atrial fibrilla-
ion had average heart rates during Holter monitoring
imilar to those without atrial fibrillation (83.3  10.5
eats/min vs. 85.2  11.7 beats/min, p  0.529).
With stepwise logistic regression analysis for predictors of
OAF, AFP maintenance was not an independent predic-
or (OR 1.18, 95% CI 0.56 to 2.49), but 4 predictors were
ound with 3 trends (Table 3).
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nterior fat pad maintenance did not positively or nega-
ively impact clinical end points, particularly POAF, in the
FIST-III study. We would have needed over 9,720
ubjects to show that this difference in POAF between the
FP maintenance and AFP removed groups was signifi-
ant. Because we were not able to impact POAF, our length
Study Demographics
Table 1 Study Demographics
Age (yrs)
Age 70 yrs (%)
Gender (% male)
History of atrial fibrillation (%)
History of other arrhythmia (%)
History of heart failure (%)
History of neurologic disease (%)
History of myocardial infarction (%)
Pre-CABG beta-blockers (%)
Pre-CABG calcium blockers (%)
Pre-CABG digoxin (%)
History of diabetes (%)
History of smoking (%)
History of chronic obstructive pulmonary disease (%)
Family history of coronary disease (%)
History of hypertension (%)
History of angina symptoms (%)
Left ventricular ejection fraction (%)
Vessels 50% stenosed (n)
Mitral regurgitation (%)
Left ventricular aneurysm (%)
Surgical characteristics
CABG  valve surgery (%)
On-pump surgery (%)
Duration of surgery (min)
Defibrillation attempts (n)
Vein grafts (n)
Artery grafts (n)
Total fluid in during surgery (ml)
Net fluid balance (ml)
Heart rate 100 beats/min 10 min (%)
Systolic blood pressure 180 mm Hg (%)
Systolic blood pressure 90 mm Hg (%)
ST-segment change (%)
Need for atrial pacing (%)
Need for ventricular pacing (%)
Inotropic agents needed (%)
Left atrial appendage stapling (%)
Medication characteristics
Beta-blockers after surgery (%)
Calcium channel blocker after surgery (%)
Digoxin after surgery (%)
Corticosteroids after surgery (%)
High-dose nonsteroidal anti-inflammatory drug (%)
Amiodarone prophylaxis (%)
Cumulative amiodarone oral dose equivalents (mg)
CABG  coronary artery bypass graft surgery; Maintained  anterior ff stay and total hospital costs were similar between groups. eur POAF data is consistent with the results of the
xtension study by Davis et al. (7). In contrast to their
andomized pilot study of 131 patients in which the
ncidence of POAF was reduced 66.3% with AFP mainte-
ance (p  0.051), the extension study (n  320, which
ncluded the 131 subjects from the pilot) showed no benefit
OR 1.0; 95% CI 0.4 to 2.4, p  1.0) (6,7). Because the
ved (n  88) Maintained (n  92) p Value
.0 10.1 65.1 8.7 0.519
42.0 31.5 0.175
77.3 80.4 0.736
4.5 4.3 1.000
10.2 5.4 0.238
9.1 9.8 0.837
9.1 6.5 0.548
50.0 45.7 0.656
81.8 77.2 0.623
12.5 6.5 0.186
1.1 0.0 0.494
36.4 32.6 0.711
60.2 72.8 0.043
19.3 14.1 0.385
38.6 44.6 0.458
76.1 79.3 0.418
64.8 64.1 0.996
.6 12.3 52.4 12.5 0.905
.8 0.6 2.9 0.4 0.239
19.3 10.9 0.135
0.0 1.1 0.999
2.2 2.2 0.999
46.6 54.3 0.232
.1 65.0 295.4 103.5 0.581
.3 1.0 0.2 0.3 0.188
.0 1.3 2.4 1.3 0.059
.9 1.2 1.8 1.2 0.580
.0 1,041.7 3,436.7 1,816.0 0.485
.1 1,370.1 1,711.9 1,644.9 0.750
8.0 9.8 0.617
14.8 9.8 0.347
38.6 28.3 0.184
5.7 5.4 0.999
9.1 3.3 0.130
12.5 5.4 0.105
77.3 80.4 0.393
26.1 28.3 0.681
83.0 85.9 0.460
9.1 12.0 0.515
10.2 9.8 0.940
25.0 23.9 0.897
29.5 28.3 0.884
28.4 27.2 0.853
.9 2,155.5 3,648.2 2,577.5 0.928
maintained; Removed  anterior fat pad removed.Remo
66
52
2
288
0
2
1
3,279
1,638
3,709xtension study was not randomized like the pilot study, it was
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Anterior Fat Pad and AF January 23, 2007:298–303ard to discern whether the results of the extension study
eflected biases associated with a convenience sample (reserving
urgery for those who were at higher risk). The study by
ummings et al. (5) was a randomized trial primarily designed
o assess parasympathetic activity in the AFP, not to assess the
mpact of AFP maintenance on POAF. However, this 55-
atient study showed an 81% reduction in POAF in the AFP
aintenance group (p  0.01). It could not be discerned
hether this represented a real phenomenon or the impact
f small sample size and chance. As an example, if 1
dditional patient in the AFP maintenance group from the
ummings trial had developed POAF and the results in the
FP removed group was the same, the results would have
ost significance (p 0.060), and if 2 subjects had developed
OAF in the AFP maintenance group, there would not
ave been a statistical trend (p  0.130).
The AFIST-III study is also at odds with canine data
howing that parasympathetic nerve activity flowing
hrough the AFP increases the inducibility for atrial fibril-
ation and that elimination of the AFP via ablation atten-
ated atrial fibrillation inducibility (1,2). In canines, AERP
Study End Points
Table 2 Study End Points
Removed
Any POAF (%) 3
Highest ventricular rate (beats/min) 140.2
Duration of POAF (h) 23.6
Post-CABG day of initiation (#) 2.2
Symptomatic POAF (%) 3
Recurrent POAF (%) 1
Safety end points
Another arrhythmia identified (%) 1
Myocardial infarction (%)
Significant hypotension (%) 8
Significant bradycardia (%) 1
In-hospital mortality (%)
Stroke (%)
Length of stay
Time from CABG to D/C (days) 7.7
Total time in hospital (h) 9.7
Cost—end points
Total hospital costs ($) 23,866 [18,
Cost data is expressed as medians [25%, 75% percentiles].
D/C  discharge from hospital; POAF  postoperative atrial fibrilla
tepwise Logistic Regressionnalysi for Predictors of P st-CABG AF
Table 3 Stepwise Logistic RegressionAnalysis for Predictors of Post-CABG AF
Independent Variables
Odds Ratio
(95% CI) p Value
Amiodarone prophylaxis 0.31 (0.13–0.74) 0.008
Age 70 yrs 2.01 (0.98–4.12) 0.058
History of AF 7.15 (1.24–41.23) 0.028
Mitral regurgitation 2.59 (1.00–6.68) 0.050
High-dose nonsteroidal anti-inflammatory
drug use
0.42 (0.17–1.01) 0.052
Beta-blocker intolerance 3.46 (1.18–10.14) 0.024rF  atrial fibrillation; CABG  coronary artery bypass graft surgery; CI  confidence interval.hortening secondary to parasympathetic nerve effects on
he atria is presumed to be the causative factor in atrial
rrhythmogenesis and is corrected after AFP ablation (1,2).
s such, it could have been predicted that AFP dissection
ould reduce POAF in clinical studies.
Evaluation of HRV might provide insight on POAF
nitiation and the role of the autonomic nervous system. In
previous trial of 96 patients undergoing thoracic surgery,
he postoperative average RR interval 5 min before the onset
f atrial fibrillation was lower (i.e., faster heart rate) than at
corresponding time from surgical control subjects (657 
12 vs. 717  134, p  0.05), suggesting elevated sympa-
hetic tone (10). However, both time-domain and frequency
omain indices of HRV were also elevated during this time,
uggesting increased parasympathetic tone interjecting in
his adrenergic-dominated environment. This would be
onsistent with canine data showing that the use of isopro-
erenol with acetylcholine can induce atrial fibrillation more
eadily than either agent alone (11).
Holter monitoring on postoperative day 2, the most com-
on day for POAF occurrence (12), did not find a difference
n resting heart rate between experimental groups, and the
eart rates were in the low- to mid-80 beats/min range in the
FIST-III study, suggesting that sympathetic dominance had
ot occurred. The HRV was higher in the AFP maintenance
roup than the control group in the AFIST-III study, sug-
esting that parasympathetic tone was enhanced. It is possible
hat the use of prophylactic beta blockade and amiodarone in
he AFIST-III study attenuated postoperative sympathetic
ominance, so the elevated parasympathetic activity with AFP
aintenance in POAF was muted (13,14).
Our study has 4 main limitations. First, the cardiotho-
88) Maintained (n  92) p Value
34.8 0.950
1 131.4 32.2 0.208
4 15.7 24.4 0.426
2.5 1.8 0.349
29.3 0.835
12.0 0.905
17.4 0.892
0.0 0.494
83.7 0.947
8.7 0.414
3.3 0.246
1.1 0.999
8.1 8.0 0.694
9.9 8.7 0.885
0,370] 22,940 [17,629, 29,274] 0.647
her abbreviations as in Table 1.(n 
5.2
 20.
 47.
 0.8
3.0
3.6
7.0
1.1
3.0
3.6
0.0
0.0
 5.1
 6.6
602, 3acic surgeons were not blinded to study group allocation.
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January 23, 2007:298–303 Anterior Fat Pad and AFe minimized the impact of this by randomizing subjects
nd having blinded data collectors, clinicians who treated
he patients, and the patients themselves. As such, unless
he surgeons had treated subjects differently in the operating
oom (aside from retaining the AFP in 1 group), there
ould not be an impact on study results. Second, we did not
ave control over the use of other prophylactic strategies to
educe POAF. We had a high and similar use of beta
lockade in both groups, so the benefits of AFP retention
ight have been attenuated by the sympathetic blockade.
lthough this might reduce the internal validity somewhat,
t enhances the external validity, because beta-blockers are
tandard-of-care prophylactic drugs in CABG surgery
13,14). It was important to discern the benefits in addition
o standard of care. The previous Davis trials did not
isclose the use of prophylactic beta-blockers, but the
ummings trial had a very high use (over 94%) of beta-
lockers (5–7). As such, the differential use of beta-blockers
ight not explain the different results between our trials,
ut dosing intensity might. However, data on beta-blocker
osing intensity are not provided in these previous trials
5–7). The previous trials also did not disclose the prophy-
actic use of amiodarone. The antiadrenergic effects of
miodarone might have accentuated the sympathetic con-
rol, and the antiarrhythmic properties might have sup-
ressed POAF in some individuals (13,14). Third, we were
nable to perform frequency domain HRV analyses. It
ould have been particularly useful to determine the high-
requency component of HRV, which is more specific to
agal tone, and the low-frequency/high-frequency ratio for
RV, because this is a more specific marker of sympathetic/
arasympathetic balance (10,11). However, a previous study
as determined that time-domain HRV indices, like in our
resent study, and frequency domain HRV indices show the
ame direction of effect in thoracic surgery patients (10).
ast, we cannot be sure that preservation or excision of the
FPs were complete in all patients, because we did not use
erve stimulation to probe the area and check for acute
hanges in sinus cycle length (1,2,5). If dissection and
reservation were not complete, residual parasympathetic
ctivity in both groups would have attenuated differential
esults that might have occurred from AFP maintenance.
onclusions. Maintaining the AFP does not alter the
ncidence of POAF after CABG or total hospital costs in
ny appreciable way, even though it preserves parasympa-
hetic tone.cknowledgments
he authors acknowledge Krista Dale, PharmD, and Sachin
hah, PharmD, for their involvement in patient recruitment
nd data collection.
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